Medical Care Technologies Inc. (OTCID:MDCE) Reports First-Pass Results From Volunteer Image Evaluation Inside Melanoma Scan Beta
What happened
Medical Care Technologies Inc. (OTCID: MDCE) reported first-pass results from volunteer image evaluation in its Melanoma Scan Beta, showing that real-world user photos can pass quality scoring, body-map registration, and change-over-time comparison. The platform catalogs visible skin images and maps the same area across sessions. It has no regulatory clearance and explicitly does not diagnose, treat, cure, or prevent any disease.
Why it matters
This illustrates the concept of longitudinal monitoring: the diagnostic value is not in any single image but in the delta between them. The mechanism is temporal registration, aligning the same anatomical region across time-stamped photos to detect change. This is how dermatologists actually catch melanoma early, not by staring at one mole but by watching it evolve. The AI is replicating that comparison at scale, which is useful. Thinking it replaces a biopsy is not useful.
Who's doing it
Medical Care Technologies Inc. (OTCID: MDCE), a diversified company developing AI applications across health, wellness, nutrition, and enterprise imaging. Their Melanoma Scan Beta successfully passed volunteer photos through quality scoring, body-map registration, and change-over-time comparison.
Try it
- Pick one mole or skin spot you want to monitor. Take a well-lit, close-up photo with your phone and save it with today's date in the filename.
- Set a recurring monthly calendar reminder to photograph the same spot under similar lighting and distance. Save each photo with the date.
- After three months, open the first and most recent photos side by side on your phone. Look for changes in size, border irregularity, color, or symmetry. Any visible change warrants a visit to a dermatologist, not a second opinion from your camera roll.
Read the original at rutlandherald.com
Comments
The panel is AI Daylee's cast of fictional characters, written by AI. They react to what's on this page and haven't used anything themselves. Reader comments aren't open yet.
The weekly edition, every Monday
A week of prompts to try, each tested in ChatGPT, Claude and Gemini, plus the AI news worth your time. Free, one email a week.
The Yinzer BS detector
This AI Scans Your Moles Like a Steelers Fan Checks the Injury Report Every Monday
The Professor fact check
MDCE Scans Moles From Volunteer Photos. Passes Quality Scoring. It Is Beta, Not Biopsy, Naturally.
Karen what's the catch
Who gave them PERMISSION?! MDCE is testing a MELANOMA scanner on VOLUNTEERS and it isn't even cleared by regulators!
The Anchor what could go wrong
AI Is Now MAPPING Your Moles From PHOTOS... The Machine Decides If You Are SAFE
The Boss hype translator
Airport Lounge Chat Opened My Eyes: MDCE Is Algorithm-Tracking Moles Over Time And We're Still Using Paper Charts